AGO1 and neoplasm: Consistent results were obtained in vivo in ESCA, STAD, and LUSC tumor tissues, where transcriptional activation of AGO1-V2 was found to be associated with increased methylation of all or most CpGs that were probed in the AGO1 promoter region (Figure 5B).